Back
CRISPR Therapeutics AG Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
2
CRSP
CRISPR Therapeutics AG
Last Price:
$36.99
Seasonality Move:
19.69%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.26 | Sell |
| 20-day SMA: | 41.91 | Sell |
| 50-day SMA: | 42.66 | Sell |
| 200-day SMA: | 47.96 | Sell |
| 8-day EMA: | 32.44 | Buy |
| 20-day EMA: | 19.99 | Buy |
| 50-day EMA: | 9.74 | Buy |
| 200-day EMA: | 2.7 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.64 | Buy |
| Relative Strength Index (14 RSI): | 34.31 | Sell |
| Chaikin Money Flow: | -1450932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.04 - 45.48) | Sell |
| Bollinger Bands (100): | (40.12 - 48.94) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 36.99 while CRSP 8-day simple moving average is 40.26, which is a Sell signal.
-
The stock price of CRSP is 36.99 while CRISPR Therapeutics AG 20-day SMA is 41.91, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 42.66 while CRSP share price is 36.99, making it a Sell technically.
-
CRSP stock price is 36.99 and CRISPR Therapeutics AG 200-day simple moving average is 47.96, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
2
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $36.99. The Score for CRSP is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.2B
Price in USD:
36.99
Share Volume:
1.6M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
70.12
52-Week Low:
36.52
Sell
2
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 36.99 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 36.99 while CRSP 8-day exponential moving average is 32.44, which is a Buy signal.
-
The stock price of CRSP is 36.99 while CRISPR Therapeutics AG 20-day EMA is 19.99, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 9.74 while CRSP share price is 36.99, making it a Buy technically.
-
CRSP stock price is 36.99 and CRISPR Therapeutics AG 200-day simple moving average is 2.70, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 10.64, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 34.31, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (40.04 - 45.48), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (40.12 - 48.94), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.